BOS Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,930
Closed -$202K 199
2025
Q3
$202K Sell
7,930
-863
-10% -$21.3K 0.06% 187
2025
Q2
$213K Sell
8,793
-447
-5% -$10.4K 0.07% 167
2025
Q1
$234K Buy
9,240
+100
+1% +$2.62K 0.08% 146
2024
Q4
$242K Sell
9,140
-200
-2% -$5.42K 0.09% 141
2024
Q3
$270K Hold
9,340
0.1% 128
2024
Q2
$261K Sell
9,340
-600
-6% -$16.5K 0.12% 125
2024
Q1
$276K Sell
9,940
-351
-3% -$9.74K 0.14% 115
2023
Q4
$296K Buy
10,291
+1,361
+15% +$41.1K 0.2% 111
2023
Q3
$296K Sell
8,930
-440
-5% -$15.6K 0.22% 98
2023
Q2
$344K Buy
9,370
+637
+7% +$24.8K 0.27% 80
2023
Q1
$356K Sell
8,733
-792
-8% -$34.2K 0.3% 78
2022
Q4
$488K Buy
+9,525
New +$457K 0.44% 63

Other funds holding PFE

BOS Asset Management's PFE Position: Q4 2025 in Review

BOS Asset Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 7,930 shares — an estimated $202K sold.

BOS Asset Management first reported a position in PFE in Q4 2022 and held it in 12 quarters. The position peaked at $488K in Q4 2022. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • BOS Asset Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • BOS Asset Management sold 7,930 Pfizer shares in Q4 2025, an estimated $202K.
  • BOS Asset Management first reported a position in Pfizer in Q4 2022 and held it in 12 quarters.
  • BOS Asset Management's Pfizer position peaked at $488K in Q4 2022.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on BOS Asset Management's 13F filing for Q4 2025, filed 9 Jan 2026.